+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medical Devices Reimbursement Market Size, Share & Trends Analysis Report By Payer (Public, Private), By Healthcare Setting (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 275 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 5415513
The global medical devices reimbursement market size is expected to reach USD 1028.2 billion by 2030, expanding at a CAGR of 8.8% from 2023 to 2030. Medical device reimbursement is defined as the payment a third-party private or public insurer pays a healthcare provider for the cost incurred while using medical equipment. The major factors fueling the industry growth are growing dependence on reimbursement, the increasing prevalence of chronic diseases, and growing preventive care. Focus on early diagnostics and preventive care may in turn lead to higher activity within the diagnostic device industry, thus promoting more reimbursement share from them.

For instance, a fundamental paradigm shift towards incentivizing early diagnosis through reimbursement has been noticed across developed economies, such as thorough screening for breast cancer. During the COVID-19 pandemic, surgeries such as robotic-assisted procedures were postponed. However, during the pandemic recovery period, these surgeries are expected to improve particularly in Asia pacific as the countries such as Japan and China are actively involved in providing reimbursement to robotic-assisted providers to improve the accuracy of surgeries. Such initiatives are likely to have a positive impact on market growth in the post-pandemic period. With an increasing demand for medical equipment, reimbursement services are expected to provide various opportunities for healthcare industries to poach upon. Additionally, the increasing number of people pursuing insurance and consolidation of the healthcare system are major factors fueling the industry growth.

North America dominated the market with a revenue share of over 50.2% in 2022 and is expected to maintain its dominance over the forecast period. The rising demand for healthcare equipment and the increasing number of healthcare centers are expected to drive the industry in this region. The growing prevalence of chronic diseases is driving the demand for various healthcare instruments. This is further expected to support the growth of the regional market. Over the years, the Centers for Medicare & Medicaid Services have reduced the reimbursement for diagnostic radiology in the U.S. For instance, in January 2022, a study published in Science Direct stated that, between 2011 - 2021, there was a steady decline in the reimbursement for diagnostic imaging studies. A continuation of this trend by the government agencies is expected to have a negative impact on the regional market growth in the post-pandemic period.

Medical Devices Reimbursement Market Report Highlights

  • The private payer segment dominated the market with a revenue share of over 65.0% in 2022 due to the presence of a large number of private players
  • By healthcare setting, the hospitals segment held the largest revenue share of over 51.8% in 2022 due to recent technological developments and high patient footfall requiring the use of healthcare instruments
  • Asia Pacific is projected to witness rapid growth during the forecast period owing to the rising penetration of insurance services in rural and urban areas

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Payer
1.1.2. Healthcare Setting
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Payer outlook
2.2.2. Healthcare Setting outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Medical Device Reimbursement Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Medical Device Reimbursement Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Medical Device Reimbursement: Payer Estimates & Trend Analysis
4.1. Medical Device Reimbursement Market: Key Takeaways
4.2. Medical Device Reimbursement Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Public
4.3.1. Public market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Private
4.4.1. Private market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Medical Device Reimbursement: Healthcare Setting Estimates & Trend Analysis
5.1. Medical Device Reimbursement Market: Key Takeaways
5.2. Medical Device Reimbursement Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Hospitals
5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Outpatient facilities
5.4.1. Outpatient facilities market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Others
5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Medical Device Reimbursement Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Medical Device Reimbursement Market by Region: Key Takeaways
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. UnitedHealth Group
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Cigna
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Humana Inc.
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Allianz
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Aviva
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. CVS Health
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. WellCare Health Plans
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Nippon Life Insurance Company
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. BNP Paribas
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Anthem Insurance Companies, Inc.
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 3 North America medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 4 North America medical device reimbursement market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 6 U.S. medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 7 Canada medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 8 Canada medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 9 Europe medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 10 Europe medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 11 Europe medical device reimbursement market, by region, 2018 - 2030 (USD Million)
Table 12 Germany medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 13 Germany medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 14 UK medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 15 UK medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 16 France medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 17 France medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 18 Italy medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 19 Italy medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 20 Spain medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 21 Spain medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 22 Sweden medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 23 Sweden medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 24 Norway medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 25 Norway medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 26 Denmark medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 27 Denmark medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 28 Asia Pacific medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 29 Asia Pacific medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 30 Asia Pacific medical device reimbursement market, by region, 2018 - 2030 (USD Million)
Table 31 China medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 32 China medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 33 Japan medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 34 Japan medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 35 India medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 36 India medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 37 Australia medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 38 Australia medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 39 Thailand medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 40 Thailand medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 41 South Korea medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 42 South Korea medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 43 Latin America medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 44 Latin America medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 45 Latin America medical device reimbursement market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 47 Brazil medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 48 Mexico medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 49 Mexico medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 50 Mexico medical device reimbursement market, by application, 2018 - 2030 (USD Million)
Table 51 Argentina medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 52 Argentina medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 55 Middle East and Africa medical device reimbursement market, by region, 2018 - 2030 (USD Million)
Table 56 South Africa medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 57 South Africa medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 59 Saudi Arabia medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 60 UAE medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 61 UAE medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
Table 62 Kuwait medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
Table 63 Kuwait medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Medical device reimbursement: Market outlook
Fig. 9 Medical device reimbursement: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Medical device reimbursement market driver impact
Fig. 15 Medical device reimbursement market restraint impact
Fig. 16 Medical device reimbursement market strategic initiatives analysis
Fig. 17 Medical device reimbursement market: Payer movement analysis
Fig. 18 Medical device reimbursement market: Payer outlook and key takeaways
Fig. 19 Public market estimates and forecasts, 2018 - 2030
Fig. 20 Private market estimates and forecasts, 2018 - 2030
Fig. 21 Medical device reimbursement market: Healthcare setting movement analysis
Fig. 22 Medical device reimbursement market: Healthcare setting outlook and key takeaways
Fig. 23 Hospital market estimates and forecasts, 2018 - 2030
Fig. 24 Outpatient facilities market estimates and forecasts, 2018 - 2030
Fig. 25 Other market estimates and forecasts, 2018 - 2030
Fig. 26 Global medical device reimbursement market: Regional movement analysis
Fig. 27 Global medical device reimbursement market: Regional outlook and key takeaways
Fig. 28 North America market estimates and forecasts, 2018 - 2030
Fig. 29 U.S. market estimates and forecasts, 2018 - 2030
Fig. 30 Canada market estimates and forecasts, 2018 - 2030
Fig. 31 Europe. market estimates and forecasts, 2018 - 2030
Fig. 32 UK market estimates and forecasts, 2018 - 2030
Fig. 33 Germany market estimates and forecasts, 2018 - 2030
Fig. 34 France market estimates and forecasts, 2018 - 2030
Fig. 35 Italy market estimates and forecasts, 2018 - 2030
Fig. 36 Spain market estimates and forecasts, 2018 - 2030
Fig. 37 Sweden market estimates and forecasts, 2018 - 2030
Fig. 38 Norway market estimates and forecasts, 2018 - 2030
Fig. 39 Denmark market estimates and forecasts, 2018 - 2030
Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 41 Japan market estimates and forecasts, 2018 - 2030
Fig. 42 China market estimates and forecasts, 2018 - 2030
Fig. 43 India market estimates and forecasts, 2018 - 2030
Fig. 44 Australia market estimates and forecasts, 2018 - 2030
Fig. 45 Thailand market estimates and forecasts, 2018 - 2030
Fig. 46 South Korea market estimates and forecasts, 2018 - 2030
Fig. 47 Latin America market estimates and forecasts, 2018 - 2030
Fig. 48 Brazil market estimates and forecasts, 2018 - 2030
Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
Fig. 50 Argentina market estimates and forecasts, 2018 - 2030
Fig. 51 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 53 South Africa market estimates and forecasts, 2018 - 2030
Fig. 54 UAE market estimates and forecasts, 2018 - 2030
Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030

Companies Mentioned

  • Unitedhealth Group
  • Cigna
  • Humana Inc.
  • Allianz
  • Aviva
  • CVS Health
  • WellCare Health Plans
  • Nippon Life Insurance Company
  • BNP Paribas
  • Anthem Insurance Companies, Inc.

Methodology

Loading
LOADING...

Table Information